SIGN UP
LOG IN
News
Suzhou Basecare Medical
--
--
0.00%
Weekly Report: what happened at Suzhou Basecare Medical last week (0428-0502)?
Weekly Report · 4d ago
Weekly Report: what happened at Suzhou Basecare Medical last week (0421-0425)?
Weekly Report · 04/27 22:04
Suzhou Basecare Medical Full Year 2024 Earnings: CN¥0.87 loss per share (vs CN¥0.70 loss in FY 2023)
Simply Wall St · 04/25 23:12
Weekly Report: what happened at Suzhou Basecare Medical last week (0414-0418)?
Weekly Report · 04/20 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0407-0411)?
Weekly Report · 04/13 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0331-0404)?
Weekly Report · 04/06 22:03
Weekly Report: what happened at Suzhou Basecare Medical last week (0324-0328)?
Weekly Report · 03/30 22:03
Weekly Report: what happened at Suzhou Basecare Medical last week (0317-0321)?
Weekly Report · 03/23 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0310-0314)?
Weekly Report · 03/16 22:03
Weekly Report: what happened at Suzhou Basecare Medical last week (0303-0307)?
Weekly Report · 03/09 22:03
Subdued Growth No Barrier To Suzhou Basecare Medical Corporation Limited's (HKG:2170) Price
Simply Wall St · 03/05 23:25
Weekly Report: what happened at Suzhou Basecare Medical last week (0224-0228)?
Weekly Report · 03/02 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0217-0221)?
Weekly Report · 02/23 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0210-0214)?
Weekly Report · 02/16 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0203-0207)?
Weekly Report · 02/09 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0127-0131)?
Weekly Report · 02/02 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0120-0124)?
Weekly Report · 01/26 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0113-0117)?
Weekly Report · 01/19 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (0106-0110)?
Weekly Report · 01/12 22:04
Weekly Report: what happened at Suzhou Basecare Medical last week (1230-0103)?
Weekly Report · 01/05 22:03
About Suzhou Basecare Medical
Suzhou Basecare Medical Corp Ltd, formerly Jiangsu Double Helix Biology Science and Technology Co Ltd, is a China-based investment holding company mainly engaged in the provision of assisted reproductive genetic testing solutions. The Company provides genetic testing solutions and sells genetic testing equipment and instruments. The genetic testing solutions include sales of testing kits and provision of testing services. The Company's main products include PGT-A kits. The Company mainly conducts business within the domestic market.
MoreRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.